Last reviewed · How we verify
NCT04266834
Establishing Clinical Utility of a New Diagnostic Test in Patients Undergoing Cardiac Catheterization
NA trial testing Experimental Arm in AKI in 157 participants. Completed in 30 June 2020.
1 June 2020
Quick facts
| Lead sponsor | Qure Healthcare, LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 157 |
| Start date | 1 December 2019 |
| Primary completion | 1 June 2020 |
| Estimated completion | 30 June 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Experimental Arm
Conditions studied
- AKI — all drugs for AKI →
- Contrast-induced Nephropathy — all drugs for Contrast-induced Nephropathy →
Sponsor
Qure Healthcare, LLC — full company profile →
Who can join
Eligibility, any sex, with AKI or Contrast-induced Nephropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will collect high-quality randomized controlled data across the U.S. from practicing cardiologists performing invasive/interventional procedures and determine how they currently manage patients at risk for CIN and how the results of Hikari's L-FABP test change clinical decision making.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04266834
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Experimental Arm
Trials testing the same drug.
- NCT06972719 — Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy · NA · recruiting
- NCT04298866 — White Matter Hyperintensities Subtypes in Cerebral Small Vessel Disease : 7 Tesla Ultra-high Resolution Imaging MRI · NA · unknown
- NCT04266821 — Establishing Clinical Utility of a New Diagnostic Test for Patients Suffering From Pain: A CPV® Randomized Controlled Tr · NA · completed
- NCT04204018 — Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia · NA · completed
Other recruiting trials for AKI
Currently open trials in the same condition.
- NCT07262320 — Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America · recruiting
- NCT06596811 — Research on the Risk Warning Model and Prevention Strategies for Acute Kidney Injury Associated With Cyclosporine Based · active not recruiting
- NCT06596798 — Deep Learning Model and Risk Factors for Tacrolimus-related Acute Kidney Injury · active not recruiting
- NCT04216927 — NO During CPB in Neonates to Reduce Risk of AKI · Phase 3 · recruiting
- NCT04114747 — Renal Physiology During Continuous Renal Replacement Therapy · NA · recruiting
Other Qure Healthcare, LLC trials
Trials by the same sponsor.
- NCT07099001 — Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay · NA · completed
- NCT05702385 — Clinical Utility Study for Exo-PDAC · NA · withdrawn
- NCT05603299 — Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test · NA · withdrawn
- NCT05910697 — Clinical Utility of MyProstateScore 2.0 P2 · NA · terminated
- NCT05525806 — Clinical Utility Study for MyProstateScore+ · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04266834 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qure Healthcare, LLC
- Last refreshed: 16 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04266834.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing